The results showed that, except for esophageal cancer and pancreatic cancer, the remaining 29 tumors showed significant positive correlations between TBXAS1 and immune scores, stromal scores and tumor purity scores, indicating that TBXAS1 may have a correlation with the immune microenvironment in various tumors (Figure 5C). This evidence concerns the gene TBXAS1 and pancreatic neoplasm.